Try the modernized ClinicalTrials.gov beta website. Learn more about the modernization effort.
Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

Effectiveness of Health Literacy Education (HL)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT04868487
Recruitment Status : Completed
First Posted : May 3, 2021
Last Update Posted : May 6, 2021
Sponsor:
Information provided by (Responsible Party):
Ayşegül Akca, Ankara Yildirim Beyazıt University

Study Description
Go to 
Top of Page Study Description Study Design Arms and Interventions Outcome Measures Eligibility Criteria Contacts and Locations More Information
Brief Summary:
To determine the effect of health literacy education given to nursing students. The study was conducted at two university nursing departments in Turkey between December 2018 and March 2019. A total of 206 nursing students, 103 in the intervention and 103 in the control group, were included in the study. Health literacy education, consisting of four sessions, was given to the intervention group.

Condition or disease Intervention/treatment Phase
Health Literacy Level Other: Health Literacy Education Not Applicable

Study Design
Go to 
Top of Page Study Description Study Design Arms and Interventions Outcome Measures Eligibility Criteria Contacts and Locations More Information

Layout table for study information
Study Type : Interventional  (Clinical Trial)
Actual Enrollment : 206 participants
Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: Single (Participant)
Primary Purpose: Other
Official Title: Effectiveness of Health Literacy Education for Nursing Students in Turkey
Actual Study Start Date : December 1, 2018
Actual Primary Completion Date : March 31, 2019
Actual Study Completion Date : May 15, 2019

Resource links provided by the National Library of Medicine

MedlinePlus related topics: Health Literacy

Arms and Interventions
Go to 
Top of Page Study Description Study Design Arms and Interventions Outcome Measures Eligibility Criteria Contacts and Locations More Information

Arm Intervention/treatment
Experimental: Intervention
The intervention group received four weekly training sessions of health literacy education. Each educational session lasted an average of 50 minutes. The students were divided into four groups with an average of 25 students in each group.
 Other: Health Literacy Education
Health literacy education, consisting of four sessions, was given to the intervention group.
No Intervention: Control
The control group had no educational interaction with the researcher after the pre-test. The control group was administered the one-week and three-month posttest THLS-32 by the researcher simultaneously with the intervention group.


Outcome Measures
Go to 
Top of Page Study Description Study Design Arms and Interventions Outcome Measures Eligibility Criteria Contacts and Locations More Information

Primary Outcome Measures :
  1. Health literacy level (the Turkey's Health Literacy Scale (THLS-32)) [ Time Frame: before the implementation ]
    The level of health literacy was evaluated in four categories according to the score obtained: (0-25) points: inadequate health literacy, (> 25-33) points: problematic - limited health literacy, (> 33-42) points: adequate health literacy, and (> 42-50) points: excellent health literacy. The health literacy level of the students was determined and the intervention and control group was selected from among the students with insufficient and problematic-limited health literacy level.

  2. Health literacy level (the Turkey's Health Literacy Scale (THLS-32)) [ Time Frame: one week after the implementation ]
    The health literacy levels of the students who received and did not receive the intervention were compared. The level of health literacy was evaluated in four categories according to the score obtained: (0-25) points: inadequate health literacy, (> 25-33) points: problematic - limited health literacy, (> 33-42) points: adequate health literacy, and (> 42-50) points: excellent health literacy.

  3. Health literacy level (the Turkey's Health Literacy Scale (THLS-32)) [ Time Frame: three months after the implementation. ]
    The health literacy levels of the students who received and did not receive the intervention were compared. The level of health literacy was evaluated in four categories according to the score obtained: (0-25) points: inadequate health literacy, (> 25-33) points: problematic - limited health literacy, (> 33-42) points: adequate health literacy, and (> 42-50) points: excellent health literacy.


Eligibility Criteria
Go to 
Top of Page Study Description Study Design Arms and Interventions Outcome Measures Eligibility Criteria Contacts and Locations More Information

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Layout table for eligibility information
Ages Eligible for Study:   18 Years to 32 Years   (Adult)
Sexes Eligible for Study:   All
Gender Based Eligibility:   Yes
Accepts Healthy Volunteers:   Yes
Criteria

Inclusion Criteria:

  • Inadequate (0-25 points) health literacy level
  • Problematic-limited (25-33 points) health literacy level
  • Accepting to participate in the research
  • Accepting to participate in the research

Exclusion Criteria:

  • Adequate (33-42 points) health literacy level
  • Excellent (42-50 points) health literacy level
  • Foreign language students with limited language proficiency
  • Visual-hearing disability
  • Having a neuropsychiatric disease
Contacts and Locations
Go to 
Top of Page Study Description Study Design Arms and Interventions Outcome Measures Eligibility Criteria Contacts and Locations More Information

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT04868487


Locations
Layout table for location information
Turkey
Ankara Yıldırım Beyazıt University
Ankara, Çubuk, Turkey, 06760
Sponsors and Collaborators
Ayşegül Akca
More Information
Go to 
Top of Page Study Description Study Design Arms and Interventions Outcome Measures Eligibility Criteria Contacts and Locations More Information
Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):

Layout table for additonal information
Responsible Party: Ayşegül Akca, Research Assistant, Ankara Yildirim Beyazıt University
ClinicalTrials.gov Identifier: NCT04868487    
Other Study ID Numbers: 2018-455
First Posted: May 3, 2021    Key Record Dates
Last Update Posted: May 6, 2021
Last Verified: May 2021
Individual Participant Data (IPD) Sharing Statement:
Plan to Share IPD: No

Layout table for additional information
Studies a U.S. FDA-regulated Drug Product: No
Studies a U.S. FDA-regulated Device Product: No
Keywords provided by Ayşegül Akca, Ankara Yildirim Beyazıt University:
health literacy
nursing education
undergraduate student
education